(GHC) Graham Holdings - Overview
Stock: Television, Test Preparation, Magazines, Restaurants, Healthcare
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 1.29% |
| Yield CAGR 5y | 4.49% |
| Payout Consistency | 92.3% |
| Payout Ratio | 18.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | -7.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 10.55 |
| Character TTM | |
|---|---|
| Beta | 0.761 |
| Beta Downside | 0.854 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.78% |
| CAGR/Max DD | 1.12 |
Description: GHC Graham Holdings January 10, 2026
Graham Holdings Co. (NYSE:GHC) is a diversified holding company that originated as The Washington Post Company and rebranded in 2013. Its portfolio spans education services-including test-preparation, professional-certification training, and online degree programs through Purdue University Global-as well as media properties (Foreign Policy, Slate), broadcast TV stations, restaurant and entertainment venues, and a range of industrial and healthcare businesses such as home-health services, lighting solutions, and SaaS platforms for physicians.
In FY 2023 the company reported roughly $5.5 billion in total revenue, with the Education segment contributing about 30 % and showing a 7 % year-over-year growth driven by expanding enrollment in online credential programs. Digital advertising, a key revenue source for its media assets, grew at a 5 % compound annual rate over the past three years, reflecting broader shifts toward programmatic ad spend. The broader education-services sector is being propelled by rising demand for upskilling and reskilling amid a tight labor market and increasing corporate sponsorship of certification pathways.
If you’re looking for a data-driven deep-dive on GHC’s valuation dynamics, ValueRay’s analytical toolkit offers granular segment-level metrics that can help you assess the company’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 732.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.07 > 1.0 |
| NWC/Revenue: 11.20% < 20% (prev 15.98%; Δ -4.78% < -1%) |
| CFO/TA 0.06 > 3% & CFO 435.2m > Net Income 732.4m |
| Net Debt (982.8m) to EBITDA (1.40b): 0.70 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.38m) vs 12m ago -0.14% < -2% |
| Gross Margin: 30.52% > 18% (prev 0.30%; Δ 3022 % > 0.5%) |
| Asset Turnover: 64.25% > 50% (prev 63.50%; Δ 0.75% > 0%) |
| Interest Coverage Ratio: 13.77 > 6 (EBITDA TTM 1.40b / Interest Expense TTM 87.3m) |
Altman Z'' 7.63
| A: 0.07 (Total Current Assets 2.24b - Total Current Liabilities 1.69b) / Total Assets 7.85b |
| B: 1.04 (Retained Earnings 8.18b / Total Assets 7.85b) |
| C: 0.16 (EBIT TTM 1.20b / Avg Total Assets 7.64b) |
| D: 2.59 (Book Value of Equity 8.57b / Total Liabilities 3.31b) |
| Altman-Z'' Score: 7.63 = AAA |
Beneish M -2.96
| DSRI: 1.02 (Receivables 550.4m/519.6m, Revenue 4.91b/4.71b) |
| GMI: 0.98 (GM 30.52% / 29.86%) |
| AQI: 1.01 (AQ_t 0.59 / AQ_t-1 0.59) |
| SGI: 1.04 (Revenue 4.91b / 4.71b) |
| TATA: 0.04 (NI 732.4m - CFO 435.2m) / TA 7.85b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of GHC shares?
Over the past week, the price has changed by -0.56%, over one month by +4.09%, over three months by +11.84% and over the past year by +23.51%.
Is GHC a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the GHC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 995 | -14.1% |
| Analysts Target Price | 995 | -14.1% |
| ValueRay Target Price | 1368.7 | 18.2% |
GHC Fundamental Data Overview February 03, 2026
P/S = 1.0373
P/B = 1.132
Revenue TTM = 4.91b USD
EBIT TTM = 1.20b USD
EBITDA TTM = 1.40b USD
Long Term Debt = 307.0m USD (from longTermDebt, last quarter)
Short Term Debt = 487.5m USD (from shortTermDebt, last quarter)
Debt = 1.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 982.8m USD (from netDebt column, last quarter)
Enterprise Value = 6.07b USD (5.09b + Debt 1.17b - CCE 190.8m)
Interest Coverage Ratio = 13.77 (Ebit TTM 1.20b / Interest Expense TTM 87.3m)
EV/FCF = 16.80x (Enterprise Value 6.07b / FCF TTM 361.4m)
FCF Yield = 5.95% (FCF TTM 361.4m / Enterprise Value 6.07b)
FCF Margin = 7.37% (FCF TTM 361.4m / Revenue TTM 4.91b)
Net Margin = 14.93% (Net Income TTM 732.4m / Revenue TTM 4.91b)
Gross Margin = 30.52% ((Revenue TTM 4.91b - Cost of Revenue TTM 3.41b) / Revenue TTM)
Gross Margin QoQ = 29.28% (prev 30.95%)
Tobins Q-Ratio = 0.77 (Enterprise Value 6.07b / Total Assets 7.85b)
Interest Expense / Debt = 1.46% (Interest Expense 17.2m / Debt 1.17b)
Taxrate = 31.03% (56.8m / 183.0m)
NOPAT = 829.0m (EBIT 1.20b * (1 - 31.03%))
Current Ratio = 1.32 (Total Current Assets 2.24b / Total Current Liabilities 1.69b)
Debt / Equity = 0.26 (Debt 1.17b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = 0.70 (Net Debt 982.8m / EBITDA 1.40b)
Debt / FCF = 2.72 (Net Debt 982.8m / FCF TTM 361.4m)
Total Stockholder Equity = 4.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.59% (Net Income 732.4m / Total Assets 7.85b)
RoE = 16.87% (Net Income TTM 732.4m / Total Stockholder Equity 4.34b)
RoCE = 25.87% (EBIT 1.20b / Capital Employed (Equity 4.34b + L.T.Debt 307.0m))
RoIC = 16.16% (NOPAT 829.0m / Invested Capital 5.13b)
WACC = 7.27% (E(5.09b)/V(6.26b) * Re(8.72%) + D(1.17b)/V(6.26b) * Rd(1.46%) * (1-Tc(0.31)))
Discount Rate = 8.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.53%
[DCF Debug] Terminal Value 83.66% ; FCFF base≈321.6m ; Y1≈396.7m ; Y5≈675.5m
Fair Price DCF = 3645 (EV 13.37b - Net Debt 982.8m = Equity 12.39b / Shares 3.40m; r=7.27% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -35.13 | EPS CAGR: -47.27% | SUE: -4.0 | # QB: 0
Revenue Correlation: 94.02 | Revenue CAGR: 11.06% | SUE: 2.02 | # QB: 2
EPS next Quarter (2026-03-31): EPS=14.64 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=69.60 | Chg30d=+2.250 | Revisions Net=+1 | Growth EPS=+35.7% | Growth Revenue=+8.4%